Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
tags : Preclinical crawled date : 2022 - 11 - 03 save search
Biomea Fusion to Present Preclinical Data for BMF-500, an Investigational Oral Covalent FLT3 Inhibitor, at the 64th American Society of Hematology (ASH) Annual Meeting
Published: 2022-11-03 (Crawled : 14:00) - globenewswire.com
BMEA | $10.76 -2.0% -2.04% 850K
|
Professional, Scientific, and T...
|
| O: -2.65%
H: 10.08%
C: 5.36%
bmf-500 preclinical meeting
Chinook Therapeutics Presents Updated Data from Atrasentan Phase 2 AFFINITY IgA Nephropathy (IgAN) Patient Cohort, Preclinical Atrasentan Research and Ongoing Clinical Trials at the American Society of Nephrology (ASN) Kidney Week 2022
Published: 2022-11-03 (Crawled : 14:00) - globenewswire.com
KDNY | $40.39 0.22% -0.17% 0
|
Health Technology
|
| O: -1.53%
H: 3.8%
C: 1.69%
ongoing nephropathy trials research preclinical kidney week therapeutics igan
Beam Therapeutics to Present New Preclinical Data Highlighting Non-Genotoxic Conditioning Regimens for Patients with Sickle Cell Disease Ahead of Autologous Transplant at the 64th ASH Annual Meeting
Published: 2022-11-03 (Crawled : 13:00) - globenewswire.com
BEAM | $22.74 -3.11% -3.21% 1.1M
|
Health Technology
|
| O: -2.27%
H: 6.76%
C: 3.29%
disease preclinical meeting therapeutics
Sana Biotechnology Announces Several Preclinical Data Presentations at the 64th American Society of Hematology Annual Meeting
Published: 2022-11-03 (Crawled : 13:00) - globenewswire.com
SANA | $8.58 6.06% 5.71% 1.2M
|
|
| O: -3.44%
H: 3.39%
C: -10.87%
preclinical meeting
Affimed Announces Presentation of Phase 1/2 Data from AFM13 in Combination with Allogeneic NK Cells and Preclinical AFM28 Data at ASH 2022 Annual Meeting
Published: 2022-11-03 (Crawled : 13:00) - globenewswire.com
AFMD | $4.91 -8.22% -8.96% 65K
|
Health Technology
|
| O: 11.24%
H: 15.69%
C: -1.6%
afm13 preclinical meeting afm28 presentation phase 1
Fate Therapeutics to Present Clinical and Preclinical Data for iPSC Product Platform at the 2022 ASH Annual Meeting
Published: 2022-11-03 (Crawled : 13:00) - globenewswire.com
FATE | News | $4.3 -5.29% -5.58% 2M
|
Health Technology
|
| O: -1.65%
H: 3.2%
C: -1.32%
preclinical meeting therapeutics platform
ORIC Pharmaceuticals to Present Preclinical Data on CD73 Inhibitor Program in Multiple Myeloma at the 64th American Society of Hematology (ASH) Annual Meeting
Published: 2022-11-03 (Crawled : 13:00) - globenewswire.com
ORIC | $8.08 -7.87% -8.54% 370K
|
Health Technology
|
| O: -2.62%
H: 1.92%
C: -3.46%
cd73 pharmaceuticals preclinical meeting program
Gainers vs Losers
| 62% | 38% |
Top 10 Gainers
CSSE 4 | $0.4323 183.85% 64.77% 220M
|
Consumer Services
BOF | $1.99 70.09% 41.21% 110M
|
ILAG | $0.51 6.03% 40.62% 1.7M
|
LICN | $0.941 68.04% 40.49% 15M
|
AMST | $3.31 65.5% 39.58% 70M
|
Technology Services
MTC | $3.615 61.38% 38.04% 9.3M
|
Technology Services
WIMI | $1.15 58.53% 36.92% 19M
|
Technology Services
AIH | $0.45 12.5% 30.92% 320K
|
Health Services
MULN | News | $3.78 38.46% 27.78% 13M
|
Information
RILY | $29.86 37.48% 27.26% 12M
|
Finance
Your saved searches
Save your searches and get alerts when important news are released.